{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:50:32Z","timestamp":1791039032062,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.lpm.2011.11.027","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T07:01:07Z","timestamp":1329375667000},"page":"793-806","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P1","title":["Traitement des neuropathies amylo\u00efdes h\u00e9r\u00e9ditaires"],"prefix":"10.1016","volume":"41","author":[{"given":"David","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lpm.2011.11.027_bib0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s004150170109","article-title":"Hereditary and acquired amyloid neuropathies","volume":"248","author":"Adams","year":"2001","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.lpm.2011.11.027_bib0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2011.11.027_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.1984.tb13742.x","article-title":"Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy","volume":"435","author":"Saraiva","year":"1984","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.lpm.2011.11.027_bib0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"issue":"24","key":"10.1016\/j.lpm.2011.11.027_bib0025","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1161\/hc4901.100380","article-title":"Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy","volume":"104","author":"Delahaye","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lpm.2011.11.027_bib0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/hrt.51.6.658","article-title":"Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy","volume":"51","author":"Eriksson","year":"1984","journal-title":"Br Heart J"},{"issue":"4","key":"10.1016\/j.lpm.2011.11.027_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/13506120309041740","article-title":"Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy","volume":"10","author":"Hattori","year":"2003","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.lpm.2011.11.027_bib0040","first-page":"438","article-title":"Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M)","volume":"16","author":"Lobato","year":"2003","journal-title":"J Nephrol"},{"issue":"4","key":"10.1016\/j.lpm.2011.11.027_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bjo.81.4.295","article-title":"Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow-up","volume":"81","author":"Ando","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.lpm.2011.11.027_bib0050","series-title":"Amyloid and amyloidosis","first-page":"88","article-title":"Forty years of experience with type I amyloid neuropathy. Review of 483\u00a0cases","author":"Coutinho","year":"1980"},{"issue":"3","key":"10.1016\/j.lpm.2011.11.027_bib0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1399-0004.1991.tb03085.x","article-title":"Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)","volume":"40","author":"Holmgren","year":"1991","journal-title":"Clin Genet"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2011.11.027_bib0060","first-page":"188","article-title":"Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)","volume":"18","author":"Wilczek","year":"2011","journal-title":"Amyloid"},{"issue":"Pt\u00a07","key":"10.1016\/j.lpm.2011.11.027_bib0065","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/brain\/123.7.1495","article-title":"The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation","volume":"123","author":"Adams","year":"2000","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.lpm.2011.11.027_bib0070","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/j.1600-6143.2007.01969.x","article-title":"Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16\u00a0years","volume":"7","author":"Yamamoto","year":"2007","journal-title":"Am J Transplant"},{"issue":"S1","key":"10.1016\/j.lpm.2011.11.027_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0035-3787(08)70044-4","article-title":"Efficacit\u00e9 \u00e0 long terme de la transplantation h\u00e9patique sur la neuropathie et la survie des patients atteints de neuropathie amylo\u00efde familiale (NAF) li\u00e9e \u00e0 une variante Met30\u00a0de la transthyr\u00e9tine","volume":"164","author":"Adams","year":"2008","journal-title":"Rev Neurol"},{"issue":"4","key":"10.1016\/j.lpm.2011.11.027_bib0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.md.0000232559.22098.c3","article-title":"Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy","volume":"85","author":"Delahaye","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.lpm.2011.11.027_bib0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/WNL.0b013e3181ea15d4","article-title":"Progression of transthyretin amyloid neuropathy after liver transplantation","volume":"75","author":"Liepnieks","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lpm.2011.11.027_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lpm.2009.02.021","article-title":"Liver transplantation for familial amyloid polyneuropathy","volume":"39","author":"Adams","year":"2010","journal-title":"Presse Med"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2011.11.027_bib0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13506129.2011.574354072","article-title":"On behalf reporting membs of FAPWTR. Long-term data from the Familial Amyloid Polyneuropathy World Transplantation Registry (FAPWTR)","volume":"18","author":"Wilczeck","year":"2011","journal-title":"Amyloid"},{"issue":"5","key":"10.1016\/j.lpm.2011.11.027_bib0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00007890-200203150-00015","article-title":"Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy. Portuguese type","volume":"73","author":"Olofsson","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.lpm.2011.11.027_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.transproceed.2010.11.014","article-title":"Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M)","volume":"43","author":"Rocha","year":"2011","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.lpm.2011.11.027_bib0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0420.2007.01098.x","article-title":"Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy","volume":"86","author":"Sandgren","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.lpm.2011.11.027_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejcts.2007.03.023","article-title":"Combined heart and liver transplantation for familial amyloidotic neuropathy","volume":"32","author":"Pilato","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.lpm.2011.11.027_bib0120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.2000.3203","article-title":"Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin","volume":"274","author":"Yazaki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.lpm.2011.11.027_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/TP.0b013e3181ac60db","article-title":"Combined heart and liver transplantation: a single-center experience","volume":"88","author":"Raichlin","year":"2009","journal-title":"Transplantation"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.lpm.2011.11.027_bib0130","first-page":"S24","article-title":"Early treatment effect of tafamidis, in transthyretin type of familial amyloid polyneuropathy","volume":"16","author":"Coelho","year":"2011","journal-title":"JPNS"},{"issue":"Suppl.","key":"10.1016\/j.lpm.2011.11.027_bib0135","first-page":"S77","article-title":"Evaluation of tafamidis efficiency in moderately severe Met30-TTR Familial Amyloid Polyneuropathy","volume":"16","author":"Lozeron","year":"2011","journal-title":"JPNS"},{"issue":"12","key":"10.1016\/j.lpm.2011.11.027_bib0140","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-007-0617-5","article-title":"A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy","volume":"254","author":"Denier","year":"2007","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.lpm.2011.11.027_bib0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2008.04.001","article-title":"The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems","volume":"31","author":"Santos","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.lpm.2011.11.027_bib0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model","volume":"20","author":"Cardoso","year":"2006","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.lpm.2011.11.027_bib0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy","volume":"1782","author":"Macedo","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lpm.2011.11.027_bib0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J Transl Med"},{"issue":"7320","key":"10.1016\/j.lpm.2011.11.027_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","article-title":"Antibodies to human serum amyloid P component eliminate visceral amyloid deposits","volume":"468","author":"Bodin","year":"2010","journal-title":"Nature"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.lpm.2011.11.027_bib0170","first-page":"121","article-title":"Preclinical development of ALN-TTR, a novel RNAI therapeutic for the treatment of transthyretin amyloidosis","volume":"16","author":"Sah","year":"2011","journal-title":"JPNS"},{"issue":"5","key":"10.1016\/j.lpm.2011.11.027_bib0175","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.20503","article-title":"Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides","volume":"33","author":"Benson","year":"2006","journal-title":"Muscle Nerve"},{"issue":"23","key":"10.1016\/j.lpm.2011.11.027_bib0180","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T04:28:15Z","timestamp":1543206495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498212000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0755498212000103"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.11.027","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}